# Economic Evaluation of the Use of Plerixafor for Autologous HSC Transplantation for Multiple Myeloma

> **NCT02861287** · — · COMPLETED · sponsor: **Institut Paoli-Calmettes** · enrollment: 60 (actual)

## Conditions studied

- Multiple Myeloma

## Interventions

- **OTHER:** Economic evaluation

## Key facts

- **NCT ID:** NCT02861287
- **Lead sponsor:** Institut Paoli-Calmettes
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01
- **Primary completion:** 2015-12
- **Final completion:** —
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2016-08-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02861287

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02861287, "Economic Evaluation of the Use of Plerixafor for Autologous HSC Transplantation for Multiple Myeloma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02861287. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*